October 8, 2020 No Comments biotech, boston dynamics, carbon health, color, coronavirus, COVID-19, crispr, Disrupt 2020, eren bali, Hardware, Health, jennifer doudna, othman laraki, Science
Tech’s role in the COVID-19 response: Assist, don’t reinvent The pandemic has affected just about every business in the world, but tech has also geared up to fight back in its own way, as we found out from speakers at Disrupt 2020. But technology has opted to take a back seat to […]
September 17, 2020 No Comments biotech, coronavirus, COVID-19, crispr, Disrupt, Disrupt 2020, jennifer doudna, TC
Jennifer Doudna sees CRISPR gene-editing tech as a Swiss Army knife for COVID-19 and beyond Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity to be “reprogrammed” like software, […]
September 3, 2020 No Comments crispr, Science, Science / Biotech
Human Embryo Gene Editing Gets a Road Map—Not a Green Light After the 2018 “Crispr baby” scandal, a global commission assessed the technology and set strict criteria for moving it toward clinical trials. Source: www.wired.com Human Embryo Gene Editing Gets a Road Map—Not a Green Light
August 13, 2020 No Comments Articles, Biology, biotech, biotechnology, california, cancer, cancer research, crispr, drugs, Health, labcorp, Life Sciences, Science, stanford, stem cells, TC, UCSF
Mission Bio raises million to help scale its tech for improving the development of targeted cancer therapies California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participating from Soleus Capital and existing investors Mayfield, Cota and Agilent. Mission Bio will use […]
August 12, 2020 No Comments Biology, biotech, biotechnology, crispr, genetic engineering, Health, Life Sciences, Mammoth Biosciences, Science, TC, uc-berkeley
Mammoth Biosciences lands exclusive license to new CRISPR proteins that could boost gene editing precision CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins, from UC Berkeley, which covers R&D and commercialization across all potential fields. This is a significant addition to Mammoth’s intellectual property […]
June 14, 2020 No Comments Arch Venture Partners, Biology, biotechnology, BlueYard Capital, cambridge university, cancer, crispr, Director, Disease, drug development, drug discovery, Foresite Capital, founder, Grail, Juno, Life Sciences, Meatable, operating system, stem cells, TC, United Kingdom
Bit Bio’s “enter button for the keyboard to the software of life” nabs the company .5 million Bit Bio, the new startup which pitches itself as the “enter button for the keyboard to the software of life” only needed three weeks to raise its latest $41.5 million round of funding. Originally known […]
April 30, 2020 No Comments Agriculture, Bayer, Bill Gates, boston, Breakthrough Energy Ventures, Canada, crispr, crops, DCVC, DNA sequencing, jeff bezos, latin america, machine learning, managing partner, Masayoshi Son, matt ocko, Mukesh Ambani, Pavilion Capital, prelude ventures, TC, temasek, United States
With fresh support from its billionaire backers Pivot Bio is ushering in a farming revolution In the first decade of the twentieth century two German chemists, Fritz Haber and Carl Bosch, invented fertilizer — the nitrogen compound which ushered in modern agriculture and saved the world from potential starvation. Now, over a […]
April 16, 2020 No Comments Biology, biotech, biotechnology, coronavirus, COVID-19, crispr, Emerging-Technologies, fda, Health, Life Sciences, Mammoth Biosciences, Science, Startups, TC, Virus
Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. The study, published in Nature, shows performance on par with existing PCR-based molecular tests, […]
January 30, 2020 No Comments Alphabet, Bayer, Broad institute, crispr, CRISPR Therapeutics, genomics, Illumina, Mammoth Biosciences, Synthego, TC, trevor martin
Mammoth Biosciences aims to be Illumina for the gene editing generation In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material. Now, a little over twenty years later, Mammoth Biosciences is hoping to do the […]
January 14, 2020 No Comments 3 D, Amazon, Amazon Technologies Inc., Android, apple inc, AT&T, biotechnology, car, China, Companies, crispr, EMC, Germany, Government, Hewlett-Packard Enterprise, huawei, IBM, industries, Japan, lawsuit, Microsoft, mpeg la, Netflix, oracle, Panasonic, patents, printing, Qualcomm, quantum computing, Samsung, Samsung Electronics, south korea, technology trends, telecommunications, United States
US patents hit record 333,530 granted in 2019; IBM, Samsung (not the FAANGs) lead the pack We may have moved on from a nearly-daily cycle of news involving tech giants sparring in courts over intellectual property infringement, but patents continue to be a major cornerstone of how companies and people measure their […]
Copyright © 2019 Kenys Empire. Created by Kenys Online. Powered by Amazon.
we are temporary having problem with the theme sorry for any inconvenience Dismiss